Showing 581 - 600 results of 2,092 for search '"chemotherapy"', query time: 0.08s Refine Results
  1. 581

    A Case of Biphasic Pulmonary Blastoma Treated with Carboplatin and Paclitaxel plus Bevacizumab by Shinya Sakata, Sho Saeki, Sayuri Hirooka, Susumu Hirosako, Hidenori Ichiyasu, Hirotsugu Kohrogi

    Published 2015-01-01
    “…Four courses of the chemotherapy were completed, but a metastasis was found and the metastatic tumor in the spleen was enlarged. …”
    Get full text
    Article
  2. 582

    Effects of Scheduled Exercise on Cancer-Related Fatigue in Women with Early Breast Cancer by Anne Marie Lunde Husebø, Sindre Mikal Dyrstad, Ingvil Mjaaland, Jon Arne Søreide, Edvin Bru

    Published 2014-01-01
    “…Data collection was performed at baseline, at completion of chemotherapy (Post1), and 6-month postchemotherapy (Post2). …”
    Get full text
    Article
  3. 583
  4. 584

    Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study by Chenming Liu, Jintao Chen, Yuxing Liu

    Published 2025-02-01
    “…This study aims to evaluate the efficacy and survival outcomes of tyrosine kinase inhibitor (TKI) versus chemotherapy rechallenge in third-line treatment for advanced mCRC patients. …”
    Get full text
    Article
  5. 585

    Surgery lengthens survival for collecting duct carcinoma: analysis of hospital-based cancer registry data in Japan by Shuya Kandori, Shuhei Suzuki, Kosuke Kojo, Bunpei Isoda, Takazo Tanaka, Satoshi Nitta, Masanobu Shiga, Yoshiyuki Nagumo, Atsushi Ikeda, Takashi Kawahara, Akio Hoshi, Hiromitsu Negoro, Bryan J. Mathis, Ayako Okuyama, Hiroyuki Nishiyama

    Published 2025-01-01
    “…The median OS of patients who undertook chemotherapy alone was significantly shorter than patients who undertook surgery alone for advanced disease (4 months [95% CI: 4-NA] vs. 15 months [95% CI: 13–68]; p < 0.001) and surgery-only patients had a similar median OS as surgery-plus-chemotherapy patients (19 months [95% CI: 13-NA]; p < 0.001). …”
    Get full text
    Article
  6. 586

    Evaluating survival outcomes and treatment recommendations in resectable gastric cancer by Saad Sabbagh, Iktej Singh Jabbal, María Herrán, Mohamed Mohanna, Sindu Iska, Mira Itani, Barbara Dominguez, Kaylee Sarna, Zeina Nahleh, Arun Nagarajan

    Published 2025-01-01
    “…Treatment modalities were classified as neoadjuvant chemotherapy (NC), neoadjuvant chemoradiotherapy (NCR), PC, adjuvant chemotherapy (AC), and adjuvant chemoradiation (ACR). …”
    Get full text
    Article
  7. 587

    Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells by Renjie Chen, Jiahui Wang, Shuoyu Huang, Xuefeng Hu, Xinran He, Tiange Zhang, Yunhan Hu, Huijun Wei, Sihui Nian, Yushu Huang, Zhihao Wu

    Published 2025-01-01
    “…Objective: Lung cancer is the most common cause of cancer-related deaths worldwide. Platinum-based chemotherapy is one of the main treatment options for patients with non-small cell lung cancer (NSCLC) but the effectiveness of chemotherapy is encumbered by drug resistance. …”
    Get full text
    Article
  8. 588
  9. 589

    Primary Lymphoepithelioma-Like Carcinoma of Lung by Alejandro Guerrero, Michael Laflamme, S Nicholas Agoff, William M Williams, Riyad Karmy-Jones

    Published 2001-01-01
    “…After it was determined that the neoplasm was of primary lung origin, adjunctive chemotherapy was initiated. The role of adjunctive chemotherapy in this setting is discussed.…”
    Get full text
    Article
  10. 590

    Acute Myeloid Leukemia Presenting with Pulmonary Tuberculosis by Merlin Thomas, Mushtak AlGherbawe

    Published 2014-01-01
    “…Thereafter the patient received induction chemotherapy and continued antituberculous treatment. …”
    Get full text
    Article
  11. 591

    Analysis and Optimization of Drug Resistant an Phase-Specific Cancer by Andrzej Swierniak, Jaroslaw Smieja

    Published 2005-07-01
    “…This paper presents analysis and biomedical implications of a certain class of bilinear systems that can be applied in modeling of cancer chemotherapy. It combines models that so far have been studied separately, taking into account both the phenomenon of gene amplification and drug specificity in chemotherapy in their different aspects. …”
    Get full text
    Article
  12. 592

    A Rare Case of Primary Anterior Mediastinal Yolk Sac Tumor in an Elderly Adult Male by Sammy G. Nakhla, Srinath Sundararajan

    Published 2016-01-01
    “…However, comorbidities can render treatment with chemotherapy and surgery challenging in elderly patients.…”
    Get full text
    Article
  13. 593

    Mixed Phenotype Acute Leukemia Presenting as Leukemia Cutis by Geetha Narayanan, M. T. Sugeeth, Lali V. Soman

    Published 2016-01-01
    “…She was started on chemotherapy with Hyper-CVAD. There is complete resolution of the skin lesions and she has achieved bone marrow remission after the first cycle of chemotherapy.…”
    Get full text
    Article
  14. 594

    Long Complete Remission Achieved with the Combination Therapy of Cisplatin and Gemcitabine in a Patient with Aggressive Natural Killer Cell Leukemia by Justin LaPorte, Lawrence Morris, John Koepke

    Published 2015-01-01
    “…We report a case of a 48-year-old male who was able to obtain a complete remission following cisplatin-based chemotherapy. We describe the details of the chemotherapy regimens used and a literature review of the treatment of ANKL.…”
    Get full text
    Article
  15. 595

    Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma by Rekha Chandran, Miklos Simon, Stephen E. Spurgeon

    Published 2013-01-01
    “…The simultaneous presentation of the Hodgkin lymphoma and multiple myeloma in the absence of prior chemotherapy or radiation is very rare. Here, we discuss a 72-year-old patient who initially presented with generalized pruritis. …”
    Get full text
    Article
  16. 596

    Exploring practical experience with different treatments in NSCLC patients with MET-deregulated: a retrospective analysis from the real world by Mengmeng Li, Jiuyan Huang, Ruyue Xing, Xinyang Du, Chunhua Wei, Huijuan Wang

    Published 2025-01-01
    “…Patients underwent varied treatments: Chemotherapy, Immune monotherapy, Crizotinib, or Savolitinib. …”
    Get full text
    Article
  17. 597

    A rare case of recurrent adenoid cystic carcinoma of the breast with weak hormone receptor positivity by Jonathan W. Ray, MD, Mena Louis, DO, Nathaniel Grabill, MD, Jaime Morel Ruiz, MD, Priscilla Strom, MD

    Published 2025-03-01
    “…Local recurrence of breast ACC can occur despite chemotherapy, surgery, and radiotherapy. Ineffectiveness of chemotherapy and recurrence after breast-conserving surgery suggest mastectomy might offer better local control. …”
    Get full text
    Article
  18. 598
  19. 599

    Vitamin E and N-Acetylcysteine as Antioxidant Adjuvant Therapy in Children with Acute Lymphoblastic Leukemia by Youssef Al-Tonbary, Mohammad Al-Haggar, Rasha EL-Ashry, Sahar EL-Dakroory, Hanan Azzam, Ashraf Fouda

    Published 2009-01-01
    “…Twenty children (group I) have taken vitamin E and NAC supplementations with chemotherapy and the other twenty children (group II) have not taken any adjuvant antioxidant therapy. …”
    Get full text
    Article
  20. 600

    Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures by Mariana Nunes, Sara Ricardo

    Published 2024-12-01
    “…Although many patients initially respond to chemotherapy, the majority of them relapse due to Carboplatin and Paclitaxel resistance. …”
    Get full text
    Article